• 1
    Einarsson K, Hellstrom K, Kallner M. Gallbladder disease in hyperlipoproteinemia. Lancet 1975; 1: 484487.
  • 2
    Ahlberg J, Angelin B, Einarsson K, Hellstrom K, Leijd B. Prevalence of gallbladder disease in hyperlipoproteinemia. Dig Dis Sci 1979; 24: 459464.
  • 3
    Small DM. The etiology and pathogenesis of gallstones. Adv Surg 1976; 10: 6385.
  • 4
    Bennion LJ, Grundy SM. Risk factors for the development of cholelithiasis in man. N Engl J Med 1978; 299: 11611167.
  • 5
    Einarsson K, Hellström K, Kallner M. Bile acid kinetics in relation to sex, serum lipids, body weights, and gallbladder disease in patients with various types of hyperlipoproteinemia. J Clin Invest 1974; 54: 13011311.
  • 6
    Angelin B, Einarsson K, Hellström K, Leijd B. Bile acid kinetics in relation to endogenous triglyceride metabolism in various types of hyperlipoproteinemia. J Lipid Res 1978; 19: 10041016.
  • 7
    Ahlberg J, Angelin B, Björkem I, Einarsson K, Leijd B. Hepatic cholesterol metabolism in normo- and hyperlipidemic patients with cholesterol gallstones. J Lipid Res 1979; 20: 107115.
  • 8
    Ahlberg J, Angelin B, Einarsson K, Hellström K, Leijid B. Biliary lipid composition in normo- and hyperlipoproteinemia. Gastroenterology 1980; 79: 9094.
  • 9
    Yoshida T, Honda A, Tanaka N, Matsuzaki Y, He B, Osuga T, Kobayashi N, et al. Simultaneous determination of mevalonate and 7 α-hydroxy-cholesterol in human plasma by gas chromatography-mass spectrometry– the indices of cholesterol and bile acid biosynthesis. J Chromatogr B 1993; 613: 185193.
  • 10
    Yoshida T, Honda A, Tanaka N, Matsuzaki Y, Shoda J, Osuga T, Miyazaki H. Determination of 7α-hydroxy-4-cholesten-3-one level in human plasma using isotope-dilution mass spectrometry and monitoring its circadian rhythm in humans as an index of bile acid biosynthesis. J Chromatogr 1994; 655: 179187.
  • 11
    Shoda J, He B, Tanaka N, Matsuzaki Y, Osuga T, Yamamori S, Miyazaki H, et al. Increase of deoxycholate in supersaturated bile of patients with cholesterol gallstone disease, and its correlation with de novo syntheses of cholesterol and bile acids in liver, gallbladder emptying, and small intestinal transit. HEPATOLOGY 1995; 108: 15341546.
  • 12
    Shoda J, He B, Tanaka N, Matsuzaki M, Yamamori S, Osuga T. Primary dual defect of cholesterol and bile acid metabolism in liver of patients with intrahepatic calculi. Gastroenterology 1995; 108: 15341546.
  • 13
    Duane WC, Hunninghake DB, Freeman ML, Pooler PA, Schlasner LA, Gebhard RL. Simvastatin, a competitive inhibitor of HMG-CoA reductase, lowers cholesterol saturation index of gallbladder bile. HEPATOLOGY 1988; 8: 11471150.
  • 14
    Beaumont JL, Carlson LA, Cooper GR, Fejfar Z, Fredrickson DS, Strasser T. Classification of hyperlipidaemia and hyperlipoproteinaemia. Bull World Health Organization 1970; 43: 891915.
  • 15
    Vagne M, Grossman MI. Cholecystokinetic potency of gastrointestinal hormones and related peptides. Am J Physiol 1968; 215: 881884.
  • 16
    Dodds WJ, Groh WJ, Darweesh RM, Lawson TL, Kishk SMA, Kern MK. Sonographic measurement of gallbladder volume. Am J Radiol 1985; 145: 10091011.
  • 17
    Pomeranz IS, Shaffer EA. Abnormal gallbladder emptying in a subgroup of patients with gallstones. Gastroenterology 1985; 88: 787791.
  • 18
    Angelin B, Backman L, Einarsson K. Hepatic cholesterol metabolism in obesity: activity of microsomal 3-hydroxy-3-methylglutaryl coenzyme A reductase. J Lipid Res 1982; 23: 770773.
  • 19
    Brooks CJW, Cole WJ, Lawrie TDV, MacLachlan J, Borthwick JH, Barret GM. Selective reactions in the analytical characterization of steroids by gas chromatography-mass spectrometry. J Steroid Biochem Mol Biol 1983; 19: 189201.
  • 20
    Allain CC, Poon LS, Chan CSG, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1974; 20: 470475.
  • 21
    Takayama M, Itoh S, Nagasaki T, Tanimura I. A new enzymatic method for determination of serum choline-containing phospholipids. Clin Chim Acta 1977; 79: 9398.
  • 22
    Aufenanger J, Kattermann R. Enzymatic determination of lipids in human bile without bilirubin interference: reliable assessment of the cholesterol saturation index (CSI). J Clin Chem Clin Biochem 1989; 27: 605611.
  • 23
    Mashige F, Tanaka N, Maki A, Kamei S, Yamanaka M. Direct spectrophotometry of total bile acids in serum. Clin Chim Acta 1981; 27: 13521356.
  • 24
    Carey M. Critical tables for calculating the cholesterol saturation of native bile. J Lipid Res 1978; 19: 945955.
  • 25
    Shoda J, Tanaka N, He B, Matsuzaki Y, Osuga T, Miyazaki H. Alterations of bile acid composition in gallstones, bile, and liver of patients with hepatolithiasis, and their etiological significance. Dig Dis Sci 1993; 38: 21302141.
  • 26
    Honda A, Shoda J, Tanaka N, Matsuzaki Y, Osuga T, Shigematsu N, Tohma M, et al. Simultaneous assay of the activities of two key enzymes in cholesterol and bile acid metabolism by gas chromatography-mass spectrometry. J Chromatogr 1991; 565: 5366.
  • 27
    Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248254.
  • 28
    Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidium thiocyanaic-phenol-chloroform extraction. Anal Biochem 1987; 162: 156159.
  • 29
    Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988; 239: 487491.
  • 30
    Luskey KL, Stevens B. Human 3-hydroxy-3-methylglutaryl coenzyme A reductase: conserved domains responsible for catalytic activity and sterolregulated degradation. J Biol Chem 1985; 260: 1027110277.
  • 31
    Noshiro M, Okuda K. Molecular cloning and sequence analysis of cDNA encoding human cholesterol 7α-hydroxylase. FEES Lett 1990; 268: 137140.
  • 32
    Schaffer R, Sniegoski LT, Welch MJ, White E, Cohen VA, Hertz HS, Mandel J, et al. Comparison of two isotope dilution mass spectrometric methods for determination of total serum cholesterol. Clin Chem 1982; 28: 58.
  • 33
    Simmonds WJ, Korman MG, Go VLW, Hofmann AF. Radioimmunoassay of conjugated cholyl bile acids in serum. Gastroenterology 1973; 65: 705711.
  • 34
    SAS/STAT User's Guide, Release 6.03. Cary, NC: SAS Institute, 1988.
  • 35
    The Lovastatin Study Group II. Therapeutic response to lovastatin (mevinolin) in nonfamilial hypercholesterolemia: a multicenter study. JAMA 1986; 256: 28292834.
  • 36
    Angelico M, the GREPCO Group. Relationships between serum lipids and cholelithiasis: observations in the GREPCO study. In: CapocacciaL, RicciG, AngelicoM, AttiliAF, eds. Epidemiology and Prevention of Gallstone Disease. Lancaster: MTP Press, 1984; 7784.
  • 37
    Scragg RK, Calvert GD, Oliver JR. Plasma lipids and insulin in gallstone disease: a case-control study. BMJ 1984; 289: 523525.
  • 38
    Ahlberg J. Serum lipid levels and hyperlipoproteinaemia in gallstone patients. Acta Chir Scand 1979; 145: 373377.
  • 39
    Kadziolka R, Nilsson S, Scherstè T. Prevalence of hyperlipoproteinemia in men with gallstone disease. Scand J Gastroenterol 1977; 12: 353355.
  • 40
    Hofhiann AF, Hofmann NE. Measurement of bile acid kinetics by isotope dilution in man. Gastroenterology 1974; 67: 314323.
  • 41
    Parker TS, McNamara DJ, Brown C, Garrigan O, Kolb R, Batwin H, Ahrens EH. Mevalonic acid in human plasma: relationship of concentration and circadian rhythm to cholesterol synthesis rates in man. Proc Natl Acad Sci U S A 1982; 79: 30373041.
  • 42
    Axelson M, Björkhem I, Reihnér E, Einarsson K. The plasma level of 7α-hydroxy-4-cholesten-3-one reflects the activity of hepatic cholesterol 7α-hydroxylase in man. FEES Lett 1991; 284: 216218.
  • 43
    Beil FU, Grundy SM, Grouse JR, Zech L. Triglyceride and cholesterol metabolism in primary hypertriglyceridemia. Arteriosclerosis 1982; 2: 4457.
  • 44
    Salen G, Nicolau G, Shefer S, Mosbach EH. Hepatic cholesterol metabolism in patients with gallstones. Gastroenterology 1975; 69: 676684.
  • 45
    Bilhartz LE, Spady DK, Dietschy JM. Inappropriate hepatic cholesterol synthesis expands the cellular pool of sterol available for recruitment by bile acids in the rat. J Clin Invest 1989; 84: 11811187.
  • 46
    Einarsson K, Angelin B. Hyperlipoproteinemia, hypolipidemic treatment, and gallstone disease. In: GrundySM, ed. Bile Acids and Atherosclerosis. Vol. 15. New York: Raven, 1986; 6797.
  • 47
    Angelin B, Rudling M, Einarsson K, Ewerth S, Leijd B, Hershon K, Brunzell J. Enterohepatic circulation of bile acids and lipoprotein metabolism. In: PaumgartnerG, StiehlA, GerokW, eds. Enterohepatic Circulations of Bile Acids and Sterol Metabolism. Lancaster: MTP Press, 1985; 159165.
  • 48
    Angelin B, Hershon KS, Brunzell JD. Bile acid metabolism in hereditary forms of hypertriglyceridemia: evidence for an increased synthesis rate in monogenic familial hypertriglyceridemia. Proc Natl Acad Sci USA 1987; 84: 54345438.
  • 49
    Duane WC. Abnormal bile acid absorption in familial hypertriglyceridemia. J Lipid Res 1995; 36: 96107.
  • 50
    Pandak WM, Vlahcevic ZR, Heuman DM, Chiang JYL, Hylemon PB. Intraduodenal, but not intravenous infusion of taurocholate down-regulate HMG-CoA reductase and cholesterol 7α-hydroxylase [Abstract]. Gastroenterology 1994; 106: 958A.
  • 51
    Petitti DB, Friedman GD, Klatsky AL. Association of a history of gallbladder disease with a reduced concentration of high density lipoprotein cholesterol. N Engl J Med 1981; 304: 13961398.